" /> Bortezomib/Daratumumab and Hyaluronidase/Dexamethasone/Lenalidomide Regimen - CISMeF





Preferred Label : Bortezomib/Daratumumab and Hyaluronidase/Dexamethasone/Lenalidomide Regimen;

NCIt synonyms : RVD Plus Darzalex Faspro; Bortezomib-Darzalex Faspro-Dexamethasone-Lenalidomide; Daratumumab-Hyaluronidase/Bortezomib/Dexamethasone/Lenalidomide; Velcade-Decadron-Revlimid Plus Darzalex Faspro Regimen; Bortezomib/Daratumumab and Hyaluronidase/Dexamethasone/Lenalidomide; Bortezomib/Dexamethasone/Lenalidomide Plus Darzalex Faspro; Bortezomib-Lenalidomide-Dexamethasone Plus Daratumumab and Hyaluronidase; Daratumumab and Hyaluronidase/Bortezomib/Dexamethasone/Lenalidomide Regimen; Bortezomib-Dexamethasone-Lenalidomide Plus Daratumumab and Hyaluronidase; Darzalex Faspro/Bortezomib/Dexamethasone/Lenalidomide Regimen; Bortezomib-Dexamethasone-Lenalidomide Plus Daratumumab and Hyaluronidase-fihj; Daratumumab and Hyaluronidase-fihj/Bortezomib/Dexamethasone/Lenalidomide Regimen; Bortezomib-Daratumumab and Hyaluronidase-Dexamethasone-Lenalidomide Regimen; Daratumumab and Recombinant Human Hyaluronidase/Bortezomib/Dexamethasone/Lenalidomide Regimen; Bortezomib/Dexamethasone/Lenalidomide Plus Daratumumab and Hyaluronidase Regimen; Bortezomib/Daratumumab and Hyaluronidase-fihj/Dexamethasone/Lenalidomide Regimen; Darzalex Faspro/Velcade/Decadron/Revlimid Regimen; Daratumumab/Hyaluronidase Plus Bortezomib-Dexamethasone-Lenalidomide; Daratumumab and Hyaluronidase-RVd Regimen; Darzalex Faspro-RVD; RVD Plus Daratumumab and Hyaluronidase;

NCIt definition : A regimen consisting of bortezomib, daratumumab and hyaluronidase, dexamethasone and lenalidomide that can be used for the treatment of plasma cell (multiple) myeloma.;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
20/06/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.